Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial
Clinical trial NCT03728881 · COMPLETED
Trial details
- NCT number
- NCT03728881
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-01
- Primary completion
- 2022-09-30
- Enrollment
- 1240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.